Anavex Life Sciences
AVXL
#9984
Rank
C$0.10 B
Marketcap
C$1.17
Share price
-12.42%
Change (1 day)
-76.70%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2026 (TTM): -C$17.68 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$57.21 Million, an increase over its 2024 earnings that were of -C$73.75 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$17.68 Million-69.1%
2025 -C$57.21 Million-22.43%
2024 -C$73.75 Million14.77%
2023 -C$64.26 Million-17.49%
2022 -C$77.88 Million22.96%
2021 -C$63.34 Million35.36%
2020 -C$46.79 Million12.65%
2019 -C$41.54 Million29.09%
2018 -C$32.18 Million36.33%
2017 -C$23.6 Million17.11%
2016 -C$20.16 Million20.91%
2015 -C$16.67 Million-6.29%
2014 -C$17.79 Million337.28%
2013 -C$4.07 Million
2008 -C$7.53 Million106.01%
2007 -C$3.66 Million8848.98%
2006 -C$0.05 Million-79.99%
2005 -C$0.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
C$87.12 M-570.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
C$0.15 B-956.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-C$11.98 Million-35.37%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-C$0.51 Billion 2,638.61%๐Ÿ‡บ๐Ÿ‡ธ USA